Pharmaco-Proteogenomic Characterization of Liver Cancer Organoids for Precision Oncology

The authors established a patient-derived liver cancer organoid biobank that comprehensively represented the histological and molecular characteristics of various liver cancer types as determined by multiomics profiling, including genomic, epigenomic, transcriptomic, and proteomic analysis.